FAP and neoplasm: These are designed to circulate systemically in an inert form and become selectively activated preferentially within the tumor microenvironment due to local conditions like specific enzymatic activity (e.g., from tumor-associated proteases such as MMPs or FAP), acidic pH, or hypoxia, which cleave masking elements or convert the prodrug.